Company / Interest Expense
NOVAVAX INC Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$11.5M
FY2025
5-year range
$10.4M / $21.1M
FY2021-FY2025
Trend
+10.5%
vs FY2024
Sector context
#26 of 44
Health Care
What the data says
At $12M, NOVAVAX INC's interest expense ranks #19 of 44 in the Health Care sector. Interest Expense returned to growth in FY2025 after 3 years of decline, reaching $12M.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of -5.3%.
Improved from $14M to $12M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -8.7%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
#19 of 44 in Health CareTop 41% of 44This company $11.5M Sector average $291.0M
▼
-96.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.3%, indicating a declining trend.
- In FY2025, interest expense increased 10.5% year-over-year.
- Ranks #26 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.5M | +10.5% |
| FY2024 | $10.4M | -27.6% |
| FY2023 | $14.4M | -4.8% |
| FY2022 | $15.1M | -28.3% |
| FY2021 | $21.1M | +39.5% |
| FY2020 | $15.1M | +7.6% |
| FY2019 | $14.1M | +8.5% |
| FY2018 | $13.0M | +5279.7% |
| FY2017 | $241.0K | +53.5% |
| FY2016 | $157.0K | -1.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026